Ionis Pharmaceuticals, Inc.
Modulation of androgen receptor expression
Last updated:
Abstract:
Certain embodiments are directed to compounds and compositions targeted to human androgen receptor (AR) for inhibiting androgen receptor levels in a cell, which can be useful for methods of treating cancer and inhibiting cancer cell growth or proliferation.
Status:
Grant
Type:
Utility
Filling date:
13 Feb 2019
Issue date:
9 Mar 2021